A vaccine trialled at Barwon Health has been approved for use on pregnant women in America to protect babies from respiratory syncytial virus (RSV). Pfizer’s Abrysvo vaccine has been approved by the US FDA as the first maternal vaccine to help protect infants at birth through six months from...

PRT-E is a unique research initiative built on partnerships with a diverse community of pregnancy care stakeholders. We’re a collaborative group of pregnancy care clinicians, community members and researchers working together to develop locally relevant and innovative solutions to complex...

The research and clinical partnership between Barwon Health and Deakin University is marking more than two decades of achievement with the announcement of a new Clinician Scientist Pathway and funding for ten new PhD candidates. The move will create Australia’s most innovative Clinician...